RS60135B1 - Vakcine protiv hlamidije sp. - Google Patents
Vakcine protiv hlamidije sp.Info
- Publication number
- RS60135B1 RS60135B1 RS20200360A RSP20200360A RS60135B1 RS 60135 B1 RS60135 B1 RS 60135B1 RS 20200360 A RS20200360 A RS 20200360A RS P20200360 A RSP20200360 A RS P20200360A RS 60135 B1 RS60135 B1 RS 60135B1
- Authority
- RS
- Serbia
- Prior art keywords
- amino acid
- acid sequence
- polypeptide
- momp
- seq
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201300155 | 2013-03-18 | ||
| DKPA201300684 | 2013-12-11 | ||
| PCT/DK2014/000015 WO2014146663A1 (en) | 2013-03-18 | 2014-03-17 | Vaccines against chlamydia sp. |
| EP14721199.9A EP2976355B1 (en) | 2013-03-18 | 2014-03-17 | Vaccines against chlamydia sp. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS60135B1 true RS60135B1 (sr) | 2020-05-29 |
Family
ID=50639248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20200360A RS60135B1 (sr) | 2013-03-18 | 2014-03-17 | Vakcine protiv hlamidije sp. |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US20140275478A1 (enExample) |
| EP (1) | EP2976355B1 (enExample) |
| JP (3) | JP2016514713A (enExample) |
| CN (2) | CN113185587A (enExample) |
| AU (1) | AU2014234765B2 (enExample) |
| BR (1) | BR112015023886B1 (enExample) |
| CA (1) | CA2907199C (enExample) |
| CY (1) | CY1122905T1 (enExample) |
| DK (1) | DK2976355T3 (enExample) |
| ES (1) | ES2781579T3 (enExample) |
| HR (1) | HRP20200511T1 (enExample) |
| HU (1) | HUE048573T2 (enExample) |
| LT (1) | LT2976355T (enExample) |
| PL (1) | PL2976355T3 (enExample) |
| PT (1) | PT2976355T (enExample) |
| RS (1) | RS60135B1 (enExample) |
| RU (1) | RU2723046C2 (enExample) |
| SI (1) | SI2976355T1 (enExample) |
| SM (1) | SMT202000160T1 (enExample) |
| WO (1) | WO2014146663A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016130667A1 (en) | 2015-02-10 | 2016-08-18 | Ohio State Innovation Foundation | Chlamydia-activated b cell platforms and methods thereof |
| CN104800841B (zh) * | 2015-03-02 | 2019-04-02 | 中国农业科学院兰州兽医研究所 | 牦牛流产衣原体灭活疫苗及其制备方法 |
| KR20170134978A (ko) * | 2015-03-24 | 2017-12-07 | 유니버시테이트 젠트 | 클라미디아 수이스의 검출을 위한 방법 및 펩타이드 |
| WO2017075653A1 (en) * | 2015-11-04 | 2017-05-11 | University Of The Sunshine Coast | Chlamydia antigens and uses thereof |
| CA3004924A1 (en) | 2015-11-10 | 2017-05-18 | Ohio State Innovation Foundation | Methods and compositions related to accelerated humoral affinity |
| NL2019320B1 (en) * | 2017-03-02 | 2018-09-21 | Biosparq B V | Diagnostic method and system for diagnosis |
| WO2018175875A1 (en) * | 2017-03-23 | 2018-09-27 | Ohio State Innovation Foundation | Recombinant chlamydia-activated b cell platforms and methods of use thereof |
| RU2721123C1 (ru) * | 2019-09-26 | 2020-05-18 | федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации | Штамм рекомбинантной псевдоаденовирусной частицы, экспрессирующий химерный ген MBL-CT666 Chlamydia trachomatis, способ его получения, иммуногенная композиция для защиты от урогенитального хламидиоза человека |
| US20240131138A1 (en) * | 2020-12-23 | 2024-04-25 | Institut National De La Santé Et De La Recherche Médicale (Inserm) | Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells |
| CN116854812B (zh) * | 2022-03-23 | 2024-09-24 | 东莞市朋志生物科技有限公司 | 抗沙眼衣原体的抗体、检测沙眼衣原体的试剂和试剂盒 |
| CN115975049A (zh) * | 2022-11-12 | 2023-04-18 | 北京成大天和生物科技有限公司 | 一种沙眼衣原体重组蛋白及其制备方法和应用 |
| AR132053A1 (es) * | 2023-03-02 | 2025-05-21 | Sanofi Pasteur | Composiciones para su uso en el tratamiento de clamidia |
| AU2024381228A1 (en) | 2023-11-13 | 2026-05-28 | Ziphius Nv | MODIFIED ALPHAVIRAL nsP3 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599231A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4599230A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4608251A (en) | 1984-11-09 | 1986-08-26 | Pitman-Moore, Inc. | LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues |
| US4601903A (en) | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
| US5869608A (en) * | 1989-03-17 | 1999-02-09 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis |
| US5837268A (en) * | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
| GB9215780D0 (en) * | 1992-07-24 | 1992-09-09 | Univ London Pharmacy | Peptide compounds |
| CA2141427C (en) * | 1992-07-31 | 2008-07-22 | Mohammed Anjam Khan | Expression of recombinant fusion proteins in attenuated bacteria |
| AU669000B2 (en) | 1992-09-18 | 1996-05-23 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Synthetic peptide vaccine for chlamydia trachomatis |
| GB9516293D0 (en) * | 1995-08-09 | 1995-10-11 | Immunova Ltee | Novel peptides and their use as vaccines |
| JP2002512622A (ja) * | 1997-05-06 | 2002-04-23 | バンダービルト ユニバーシティー | クラミジアにより引き起こされる感染の診断および管理のための抗クラミジア剤の組成物 |
| EP1345617A2 (en) * | 2000-12-22 | 2003-09-24 | Synovis Limited | Methods of modulating toll-related receptor (trr) signaling |
| US7105171B2 (en) | 2002-03-07 | 2006-09-12 | The Regents Of The University Of California | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| WO2005002619A2 (en) * | 2003-06-26 | 2005-01-13 | Chiron Corporation | Immunogenic compositions for chlamydia trachomatis |
| JP5024830B2 (ja) * | 2004-10-25 | 2012-09-12 | ステーテンズ セーラム インスティテュート | クラミジア・トラコマチス（Ｃｈｌａｍｙｄｉａｔｒａｃｈｏｍａｔｉｓ）抗原のワクチンおよび診断への使用 |
| US7964200B2 (en) * | 2005-05-18 | 2011-06-21 | Children's Hospital & Research Center At Oakland | Methods and compositions for immunizing against Chlamydia infection |
| TW201012929A (en) * | 2008-09-29 | 2010-04-01 | Univ Nat Pingtung Sci & Tech | A hybridoma cell line producing monoclonal antibodies against chalmydophila aborts |
| EP2907523B1 (en) * | 2009-01-29 | 2018-03-28 | British Columbia Cancer Agency Branch | Compositions comprising chlamydia antigens |
| US8735543B2 (en) * | 2010-05-28 | 2014-05-27 | Spixia Biotechnology Ab | Chimeric MOMP antigen |
| WO2012172042A1 (en) * | 2011-06-17 | 2012-12-20 | Universiteit Gent | Vaccines for chlamydia |
-
2014
- 2014-03-17 PL PL14721199T patent/PL2976355T3/pl unknown
- 2014-03-17 BR BR112015023886-6A patent/BR112015023886B1/pt active IP Right Grant
- 2014-03-17 EP EP14721199.9A patent/EP2976355B1/en active Active
- 2014-03-17 RU RU2015141214A patent/RU2723046C2/ru active
- 2014-03-17 LT LTEP14721199.9T patent/LT2976355T/lt unknown
- 2014-03-17 CA CA2907199A patent/CA2907199C/en active Active
- 2014-03-17 JP JP2016503549A patent/JP2016514713A/ja active Pending
- 2014-03-17 SI SI201431541T patent/SI2976355T1/sl unknown
- 2014-03-17 RS RS20200360A patent/RS60135B1/sr unknown
- 2014-03-17 AU AU2014234765A patent/AU2014234765B2/en active Active
- 2014-03-17 US US14/216,403 patent/US20140275478A1/en not_active Abandoned
- 2014-03-17 WO PCT/DK2014/000015 patent/WO2014146663A1/en not_active Ceased
- 2014-03-17 HU HUE14721199A patent/HUE048573T2/hu unknown
- 2014-03-17 ES ES14721199T patent/ES2781579T3/es active Active
- 2014-03-17 CN CN202110407442.8A patent/CN113185587A/zh active Pending
- 2014-03-17 DK DK14721199.9T patent/DK2976355T3/da active
- 2014-03-17 SM SM20200160T patent/SMT202000160T1/it unknown
- 2014-03-17 CN CN201480026477.5A patent/CN105377879B/zh active Active
- 2014-03-17 PT PT147211999T patent/PT2976355T/pt unknown
- 2014-03-17 HR HRP20200511TT patent/HRP20200511T1/hr unknown
-
2018
- 2018-04-18 US US15/956,731 patent/US10925954B2/en active Active - Reinstated
-
2019
- 2019-03-20 JP JP2019052389A patent/JP7510142B2/ja active Active
-
2020
- 2020-03-27 CY CY20201100285T patent/CY1122905T1/el unknown
-
2021
- 2021-01-22 US US17/155,264 patent/US20210205433A1/en active Pending
- 2021-09-13 JP JP2021148819A patent/JP7506930B2/ja active Active
-
2025
- 2025-05-02 US US19/197,254 patent/US12678495B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7506930B2 (ja) | クラミジア種（Ｃｈｌａｍｙｄｉａ ｓｐ．）に対するワクチン | |
| de la Maza et al. | Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go? | |
| EP0915978B1 (en) | Dna immunization against chlamydia infection | |
| RU2270865C2 (ru) | Иммуногенный полипептид, вызывающий защитный иммунный ответ против bacillus anthracis (варианты), способ его получения, нуклеиновая кислота, кодирующая его, вектор для экспрессии (варианты), способ и вакцина для предупреждения инфекции, вызванной bacillus anthracis | |
| Drew et al. | Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the: Taenia ovis 45W antigen | |
| NZ313950A (en) | A recombinant hybrid protein comprising at least one t- helper cell stimulating epitope from the omp of c. trachomatis | |
| JP3881514B2 (ja) | クラミジア感染症に対するｄｎａ免疫化 | |
| KR20190082229A (ko) | 스타필로코커스 감염에 대한 백신 구성체 및 이의 용도 | |
| US6235290B1 (en) | DNA immunization against chlaymdia infection | |
| US20120003241A1 (en) | Vaccine against botulism | |
| US7026300B2 (en) | One step immunization procedure for inducing a Chlamydia specific immune response | |
| US6696421B2 (en) | DNA immunization against chlamydia infection | |
| CN119325390A (zh) | 包含免疫原性融合多肽的猪链球菌疫苗组合物 | |
| MXPA99000521A (en) | Immunization of dna against chlamydia infection |